Mirum Pharmaceuticals, Inc.
MIRM
$100.64
$1.871.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -860.21M | -798.84M | -23.36M | -41.42M | -58.56M |
| Total Depreciation and Amortization | 25.95M | 25.07M | 24.24M | 24.23M | 24.22M |
| Total Amortization of Deferred Charges | 1.99M | 1.76M | 1.74M | 1.72M | 1.70M |
| Total Other Non-Cash Items | 544.87M | 507.24M | 72.92M | 67.56M | 62.41M |
| Change in Net Operating Assets | 60.14M | 93.80M | -19.72M | -7.39M | -20.77M |
| Cash from Operations | -227.27M | -170.98M | 55.83M | 44.69M | 9.00M |
| Capital Expenditure | -1.47M | -1.58M | -954.00K | -374.00K | -368.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -171.31M | -17.81M | -23.00M | -23.95M | -39.76M |
| Cash from Investing | -172.78M | -19.39M | -23.95M | -24.32M | -40.13M |
| Total Debt Issued | 672.44M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 308.54M | 312.46M | 40.14M | 36.48M | 24.25M |
| Repurchase of Common Stock | -474.37M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -8.60M | -- | -- | -- |
| Cash from Financing | 506.61M | 303.86M | 40.14M | 36.48M | 24.25M |
| Foreign Exchange rate Adjustments | -2.70M | 895.00K | 3.22M | 2.25M | 1.99M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 103.86M | 114.39M | 75.24M | 59.11M | -4.89M |